Theralase Technologies Inc. Cash Flow Reinvestment Rate

Latest as of September 2018: 0.05x

Theralase Technologies Inc. cash flow reinvestment rate. Theralase Technologies Inc. (TLT) has a Cash Flow Reinvestment Rate of 0.05x as of September 2018, reinvesting CA$19.98K (capex CA$19.98K ) from operating cash flow of CA$436.21K. Explore cash flow to debt ratio of Theralase Technologies Inc. to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.05x

(Capex + Investments) / Operating CF

Total Reinvested

CA$19.98K

Capex + Investments

Operating Cash Flow

CA$436.21K

CAD

Capital Expenditures

CA$19.98K

CAD

Cash Flow Reinvestment Rate of Theralase Technologies Inc. (2005–2005)

Cash flow reinvestment rate of Theralase Technologies Inc. from 2005 to 2005. Historical reinvestment intensity for Theralase Technologies Inc. across 1 annual periods. Explore how much does Theralase Technologies Inc. reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Theralase Technologies Inc. Cash Flow Reinvestment Rate by Year (2005–2005)

Theralase Technologies Inc. cash flow reinvestment rate by year from 2005 to 2005. Year-by-year capital reinvestment analysis for Theralase Technologies Inc.. For the full cash flow conversion analysis, see Theralase Technologies Inc. cash flow conversion.

Year	Reinvestment Rate	Total Reinvested (CAD)	Operating CF	Capex	YoY Change
2005	1.00x	CA$85.30K	CA$85.33K	CA$85.30K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow